Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-tryptophan is an essential α-amino acid required for the biosynthesis of proteins. It cannot be synthesized by the human body and must be obtained from dietary sources such as meat, eggs, dairy, and certain seeds. After ingestion, L-tryptophan is metabolized into several bioactive compounds including serotonin (a neurotransmitter involved in mood regulation), melatonin (a hormone regulating sleep-wake cycles), kynurenine, and niacin (vitamin B3). Its primary mechanism involves serving as a precursor to serotonin via conversion first to 5-hydroxytryptophan (5‑HTP). L‑tryptophan has been used as a dietary supplement for conditions like depression, insomnia, premenstrual dysphoric disorder, and smoking cessation; however, robust clinical evidence supporting these uses is limited. Most commercial L‑tryptophan is produced by microbial fermentation[1][2][3][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on l-tryptophan.